Macular Edema Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ALIM | B | Alimera Sciences, Inc. | -4.99 | |
OPT | B | Opthea Limited | -1.74 | |
REGN | C | Regeneron Pharmaceuticals, Inc. | -0.47 | |
RZLT | C | Rezolute, Inc. | 0.56 | |
CLSD | C | Clearside Biomedical, Inc. | -8.77 | |
OCS | D | Oculis Holding AG | 4.22 | |
EYEG | D | AB Corporate Bond ETF | 0.10 | |
KALV | D | KalVista Pharmaceuticals, Inc. | 0.50 | |
EYPT | D | EyePoint Pharmaceuticals, Inc. | -0.84 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | 3.07 |
Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBH | D | Market Vectors Biotech ETF | 9.12 | |
IBBQ | D | Invesco Nasdaq Biotechnology ETF | 8.79 | |
IBB | C | iShares Nasdaq Biotechnology Index Fund | 8.78 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 7.12 | |
BIB | D | ProShares Ultra Nasdaq Biotechnology | 6.33 |
Compare ETFs
- Macular Edema
Macular edema is a condition in which fluid accumulates in the macula, the part of the eye responsible for central vision. It can cause blurred vision, difficulty reading, and other vision problems. Macular edema can be caused by a variety of conditions, including diabetes, retinal vein occlusion, and uveitis. Treatment may include medications, laser therapy, or surgery.
Popular Now
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles